Gilead to Buy Pharmasset for $11 Billion

Gilead to Buy Pharmasset for $11 Billion

David Paul Morris/Bloomberg

A scientist at Gilead Sciences Inc. analyzes patient antibody levels at the Gilead Sciences Inc. laboratory in Foster City, California.